Tissue Graft Petitions for Inter Partes Review by RTI Surgical

On January 29, 2019, RTI Surgical, Inc. (“Petitioner”) filed three Petitions to the USPTO’s Patent Trial and Appeal Board (“Board”) related to U.S. Patent Nos. 6,569,200 (“the ‘200 Patent”), 9,579,420 (“the ‘420 Patent”), and 9,585,986 (“the ‘986 Patent”) owned by LifeNet Health (“Patent Owner”). The ‘200 Patent, ‘420 Patent, and ‘986 Patent are drawn to plasticized soft tissue grafts.

IPR2019-00571 challenges claims 1-3, 5, 7-10, 12, and 15 of the ‘200 Patent as anticipated under 35 U.S.C. § 102 and claims 1-10, 12-13, and 15 as obvious under 35 U.S.C. § 103.

IPR2019-00572 challenges claims 1-3, 5-6, 8-18, 20-21, and 24-36 of the ‘420 Patent as anticipated under 35 U.S.C. § 102 and claims 1-18, 20-22, and 24-36 as obvious under 35 U.S.C. § 103.

IPR2019-00573 challenges claims 1-6, 9-20, and 23-24 of the ‘986 Patent as anticipated under 35 U.S.C. § 102 and claims 1-27 as obvious under 35 U.S.C. § 103.

The inter partes reviews remain pending at the Board.

By:  April Breyer Menon

View Attachment (PDF)

View Attachment (PDF)

View Attachment (PDF)